COVID-19 vaccine maker Moderna is looking to deliver its shipment of vaccines promised to Germany earlier than expected, Dan Staner, its European head, stated on Thursday. The biotech firm is aiming to deliver 80 million doses by the end of 2021, a figure that is in line with the...
Sanofi and GlaxoSmithKline Plc have resumed trials for their joint COVID-19 vaccine candidate. After being faced with setbacks during their previous trials in the fall, these pharmaceutical manufacturers have improved their shot's formulation. According to a statement on Monday, this was done to improve effectiveness in people 50 years...
Japan announced on Tuesday that it will donate an additional 1.3 million doses of coronavirus vaccines to Taiwan and other neighboring countries. The additional AstraZeneca Plc doses (approximately 500,000) will bring Japan's total donations to the island to 3.9 million, Foreign Minister Toshimitsu Motegi told reporters.
According to sources in...
An array of European stock markets opened higher on Tuesday morning, despite the ongoing challenges faced by European Union member states in terms of their vaccine rollout campaigns. Following reports of blood clotting, several European nations including France, Germany, Italy, and Spain have suspended their rollout of the AstraZeneca...
Senior Argentinian officials revealed recently that the South American nation is expected to amend existing legislation in order to enable the government to accept COVID-19 vaccines that are to be donated by the United States. Some of the legal clauses that are expected to change include those pertaining to...
Private equity firm CVC Capital Partners is currently exploring a bid for UK chemical manufacturer Synthomer Plc, according to reports. The Luxembourg-based CVC currently manages approximately $111 billion in secured commitments of private equity, credit, and growth funds across Asia and Europe.
According to insiders who asked to remain anonymous,...
Britain's antiviral taskforce chair Eddie Gray hinted at Britain's interest in buying the molnupiravir, an experimental oral COVID-19 drug developed by Merck & Co Inc.
While Gray declined to comment directly on any potential talks being held between Britain and Merck & Co Inc, he did mention the following: "We...
After performing a new in-depth analysis of its major U.S. trial, pharmaceutical corporation AstraZeneca has declared its COVID-19 vaccine to be 76% effective at preventing serious cases of the illness. This figure is slightly lower than the rate that was mentioned earlier this week in a report that relied...
An Israeli health official revealed on Sunday that Israel is currently in talks with several other countries over plans to redistribute some of its surplus stock of COVID-19 vaccines. The doses, developed by vaccine makers Pfizer and BioNTech, are due to expire by the end of the month.
Hezi Levi,...
Moderna shares gained 2.2% during premarket trading on Thursday as the biotech company reported a revenue of $570 million during the fourth quarter of 2020. This revenue surge came as a result of skyrocketing sales of the Massachusetts-based company's COVID-19 vaccine, mRNA-1273.
Despite this record-high sales revenue, the biotech firm...